The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients. (Q51378731)
Jump to navigation
Jump to search
scientific article published on 17 February 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients. |
scientific article published on 17 February 2011 |
Statements
The once-daily human glucagon-like peptide-1 (GLP-1) analog liraglutide improves postprandial glucose levels in type 2 diabetes patients. (English)
1 reference
Anne Flint
1 reference
Christoph Kapitza
1 reference
Charlotte Hindsberger
1 reference
Milan Zdravkovic
1 reference
17 February 2011
1 reference
28
1 reference
3
1 reference
213-226
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference